SEC Form 4 · accession 0001354488-16-005793
Pharma-Bio Serv, Inc. · PBSV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Irving L Wiesen
Director
Period of report
Jan 2, 2016
Accepted (ET)
Jan 5, 2016 · 8:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001304161
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 2, 2016 | M | 10,000 | $0.26 | A | 24,876 | D | |
| Common StockF1 | Jan 2, 2016 | F | 2,600 | $1.00 | D | 22,276 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionF2 | $0.26 | Jan 2, 2016 | M | 10,000 | D | — | Jan 3, 2016 | Common Stock | 10,000 | 0 | D |
Explanation of responses
- F1Represents the aggregate amount of shares of Common Stock withheld for a cashless exercise.
- F2The option vested in two equal installments on July 3, 2011 and July 3, 2012.